Atlas Trials

Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients

Clinical trial NCT01098903 · COMPLETED

Trial details

NCT number
NCT01098903
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
COMPLETED
Study type
OBSERVATIONAL
Cancer
Start date
2009-01-01
Primary completion
2011-06-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.